Switching to an L/N-type Calcium Channel Blocker Shows Renoprotective Effects in Patients with Chronic Kidney Disease: the Kyoto Cilnidipine Study

By Hatta T   Takeda K   Shiotsu Y   Sugishita C   Adachi T   Kimura T   Sonomura K   Kusaba T   Kishimioto N   Narumiya H   Tanda S   Tamagaki K   Yamada K   Kameyama H   Kido H   Harada S   Bito Y   Moriguchi J   Morimoto S   Okigaki M   Itoh H   Mori Y   Nakata T   Maki K   Sasaki S   Sawada K   Matsubara H  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1417-1428

Field House Publishing

Access to resources Recommend Favorite

Antisympathetic and hemodynamic property of a dual L/N-type Ca 2+ channel blocker cilnidipine in rats

By Takahara A.   Koganei H.   Takeda T.   Iwata S.  

European Journal of Pharmacology, Vol. 434, Iss. 1, 2002-01 ,pp. : 43-47

Elsevier

Access to resources Recommend Favorite

Effects of a dual L/N-type Ca 2+ channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs

By Konda T.   Takahara A.   Maeda K.   Dohmoto H.   Yoshimoto R.  

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 117-120

Elsevier

Access to resources Recommend Favorite

Structural Modeling and Identification of Imperatorin as Novel L-type Calcium Channel Blocker

By  

Medicinal Chemistry, Vol. 9, Iss. 7, 2013-11 ,pp. : 993-998

Bentham Science Publishers

Access to resources Recommend Favorite

The L-Type Ca2+ Channel as a Therapeutic Target in Heart Disease

By  

Current Medicinal Chemistry, Vol. 16, Iss. 26, 2009-09 ,pp. : 3341-3358

Bentham Science Publishers

Access to resources Recommend Favorite